{"filing":{"accession_number":"0001193125-26-304763","cik":"0001489993","ticker":"MOBI","company_name":"Mobia Medical, Inc.","form":"8-K","filing_date":"2026-07-15","report_date":null,"primary_document":"mobi-20260714.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1489993/000119312526304763/mobi-20260714.htm"},"events":[{"id":18135,"run_id":16290,"accession_number":"0001193125-26-304763","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of Reza Zadno, Ph.D. as a new director to Mobia Medical's Board, increasing the Board size from six to seven members. Dr. Zadno was also appointed to the Compensation Committee as an independent director. This is a clear executive appointment event under Item 5.02(d), and is material as board composition changes affect corporate governance and investor assessment of the company's leadership structure.","company_name":"Mobia Medical, Inc.","ticker":"MOBI","filing_date":"2026-07-15","form":"8-K","submitted_at":null,"items":[{"id":16853,"accession_number":"0001193125-26-304763","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Reza Zadno, Ph.D. as a new director to Mobia Medical's Board, increasing the Board size from six to seven members. Dr. Zadno was also appointed to the Compensation Committee as an independent director. This is a clear executive appointment event under Item 5.02(d), and is material as board composition changes affect corporate governance and investor assessment of the company's leadership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T20:11:48.254926+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16853,"accession_number":"0001193125-26-304763","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Reza Zadno, Ph.D. as a new director to Mobia Medical's Board, increasing the Board size from six to seven members. Dr. Zadno was also appointed to the Compensation Committee as an independent director. This is a clear executive appointment event under Item 5.02(d), and is material as board composition changes affect corporate governance and investor assessment of the company's leadership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T20:11:48.254926+00:00","company_name":"Mobia Medical, Inc.","ticker":"MOBI","filing_date":"2026-07-15"}]}